EPZ-011989 trifluoroacetate

CAS No. 1598383-41-5

EPZ-011989 trifluoroacetate( EPZ011989 trifluoroacetate )

Catalog No. M12290 CAS No. 1598383-41-5

A potent, selective, orally bioavailable inhibitor of EZH2 with Ki of < 3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 274 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EPZ-011989 trifluoroacetate
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally bioavailable inhibitor of EZH2 with Ki of < 3 nM.
  • Description
    A potent, selective, orally bioavailable inhibitor of EZH2 with Ki of < 3 nM; equipotently inhibits mutant and wild-type EZH2, displays >15-fold selectivity over EZH1 and >3000-fold selectivity over other HMTs; demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma.Blood Cancer Preclinical.
  • In Vitro
    EPZ-011989 trifluoroacetate inhibits mutant and wild-type EZH2 with an Ki value of <3 nM.EPZ-011989 trifluoroacetate reduces cellular H3K27 methylation with an IC50 value of 94 nM.EPZ-011989 trifluoroacetate (0-10 μM; 11 days) has anti-proliferation effect in WSU-DLCL2 cells. Cell Proliferation Assay Cell Line:WSU-DLCL2 cells Concentration:0-10 μM Incubation Time:11 days Result:Demonstrated an average lowest cytotoxic concentration (LCC) in WSU-DLCL2 cells of 208 nM.
  • In Vivo
    EPZ-011989 trifluoroacetate (oral; 30-1000 mg/kg; single or bid; for 7 days or 21 days) can elicit robust methyl mark inhibition and antitumor activity. Animal Model:SCID mice Dosage:125, 250, 500, and 1000 mg/kg Administration:Oral; single, twice-daily (BID)for 7 days or twice-daily (BID)for 21 days Result:Provided coverage over the LCC for 24 h (1000 mg/kg ), while the 250 and 500 mg/kg doses provided coverage over this value for approximately 8 h.Observed complete ablation of the methyl mark by the end of day 7. Showed robust tumor growth inhibition, methyl mark reduction and extended total and free plasma exposure time.
  • Synonyms
    EPZ011989 trifluoroacetate
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    HMTase
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    1598383-41-5
  • Formula Weight
    719.8339
  • Molecular Formula
    C37H52F3N5O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 34 mg/mL
  • SMILES
    COCCN([C@@H]1CC[C@@H](N(C2=CC(C#CCN3CCOCC3)=CC(C(NCC4=C(C)C=C(C)NC4=O)=O)=C2C)CC)CC1)C.OC(C(F)(F)F)=O.OC(C(F)(F)F)=O
  • Chemical Name
    Benzamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-[ethyl[trans-4-[(2-methoxyethyl)methylamino]cyclohexyl]amino]-2-methyl-5-[3-(4-morpholinyl)-1-propyn-1-yl]-, 2,2,2-trifluoroacetate (1:x)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Campbell JE, et al. ACS Med Chem Lett. 2015 Mar 4;6(5):491-5. 2. Gardner EE, et al. Cancer Cell. 2017 Feb 13;31(2):286-299.
molnova catalog
related products
  • OTS193320

    OTS193320 (OTS-193320) is a potent inhibitor of protein methyltransferase SUV39H2 with IC50 of 22.2 nM.

  • UNC0379

    UNC0379 is a selective, substrate-competitive inhibitor of lysine methyltransferase SETD8 with IC50 of 7.3 uM.

  • MM-102 trifluoroacet...

    A high-affinity, small-molecule peptidomimetic inhibitor of MLL1/WDR5 protein-protein interaction with Ki of 2.4 nM.